Umbilical cord stem cell therapy for diabetes is effective, but still in the research phase.
Autologous transplantation of umbilical cord blood stem cells for the treatment of diabetes is effective for the treatment of type 1 diabetes, and there is an increasing trend in the use of umbilical cord blood stem cells carried out both domestically and internationally, and there are also many patients with diabetes cured by transplantation of umbilical cord blood stem cells, completely freeing the patient from insulin dependence, and many others who have gained control from their condition.
National studies have confirmed that stem cells have the potential to differentiate into a variety of cells, and as long as they are in the right environment, they can differentiate into the cells needed for various tissues and organs, and will replace damaged cells and restore the function of the tissues and organs again. If a certain number of autologous stem cells are transplanted into the artery-conducting pancreatic tissue, the stem cells will differentiate and proliferate into islet-like cells and replace the damaged islet cells to continue to secrete insulin and restore the function of the pancreas to normal, thus acting as a cure for diabetes.
Although there are some clinical research cases that confirm the effectiveness of autologous transplanted stem cells in treating patients with diabetes, they are also in their infancy and not mature. Further clinical studies are needed. Moreover, preservation of cord blood is expensive and grows with age, and is unaffordable to the average family, so it cannot be widely used.
If patients want to treat their diabetes with umbilical cord stem cell transplantation, ordinary hospitals cannot do so and they need to ask at a regular, authoritative major hospital.